|
|
The Clinical Status of Corneal Surface Refractive Surgery in the Era of Femtosecond Lasers |
Fengju Zhang,Mingshen Sun |
Beijing Tongren Eye Center, Beijing Tongren Hospital of Capital Medical University, Beijing Key Lab of Ophthalmology & Visual Sciences, Beijing 100730, China |
|
|
Abstract Due to the diversity of femtosecond laser corneal refractive surgery, it is of great importance to advocate choosing customized procedures according to each patient's ocular biological parameters. Currently,femtosecond laser corneal refractive surgery has become the mainstream procedure to correct refractive
errors. This article evaluates the clinical status of the corneal surface refractive surgery by excimer laser,aiming to provide a reference for reasonable clinical application.
|
Received: 12 January 2017
|
Fund: This study was funded by Beijing Health System High Level Health Technology Talent Fund(2013-2-023) |
Corresponding Authors:
Fengju Zhang, Beijing Tongren Eye Center, Beijing Tongren Hospital of Capital Medical University, Beijing Key Lab of Ophthalmology & Visual Sciences, Beijing 100730, China (Email:wxw93@hotmail.com)
|
|
|
|
[2] |
McDonald MB, Liu JC, Byrd TJ, et al. Central photorefractive keratectomy for myopia. Partially sighted and normally sighted eyes. Ophthalmology, 1991, 98(9): 1327-1337.
|
[1] |
Trokel SL, Srinivasan R, Braren B. Excimer laser surgery of the cornea. Am J Ophthalmol, 1983, 96(6): 710-715.
|
[3] |
Camellin M. LASEK may offer advantages of both LASIK and PRK. Ocu Surg N Int, 1999, 10(3): 14-15.
|
[4] |
Angunawela RI, Winkler vMC, Kumar A, et al. Live or let die:Epithelial flap vitality and keratocyte proliferation following LASEK and Epi-LASIK in human donor and porcine eyes. J Refract Surg, 2011, 27(2): 111-118. DOI: 10.3928/1081597X-20100330-01.
|
[2] |
McDonald MB, Liu JC, Byrd TJ, et al. Central photorefractive keratectomy for myopia. Partially sighted and normally sighted eyes. Ophthalmology, 1991, 98(9): 1327-1337.
|
[5] |
Zhao LQ, Wei RL, Cheng JW, et al. Meta-analysis: clinical outcomes of laser-assisted subepithelial keratectomy and
|
|
photorefractive keratectomy in myopia. Ophthalmology, 2010,117(10): 1912-1922. DOI: 10.1016/j.ophtha.2010.02.004.
|
[3] |
Camellin M. LASEK may offer advantages of both LASIK and PRK. Ocu Surg N Int, 1999, 10(3): 14-15.
|
[4] |
Angunawela RI, Winkler vMC, Kumar A, et al. Live or let die:Epithelial flap vitality and keratocyte proliferation following LASEK and Epi-LASIK in human donor and porcine eyes. J Refract Surg, 2011, 27(2): 111-118. DOI: 10.3928/1081597X-20100330-01.
|
[6] |
Pallikaris IG, Katsanevaki VJ, Kalyvianaki MI, et al. Advances in subepithelial excimer refractive surgery techniques:
|
[5] |
Zhao LQ, Wei RL, Cheng JW, et al. Meta-analysis: clinical outcomes of laser-assisted subepithelial keratectomy and
|
|
photorefractive keratectomy in myopia. Ophthalmology, 2010,117(10): 1912-1922. DOI: 10.1016/j.ophtha.2010.02.004.
|
|
Epi-LASIK. Curr Opin Ophthalmol, 2003, 14(4): 207-212.
|
[6] |
Pallikaris IG, Katsanevaki VJ, Kalyvianaki MI, et al. Advances in subepithelial excimer refractive surgery techniques:
|
[7] |
Winkler von Mohrensfels C, Khoramnia R, Maier M, et al.EpiLASIK with mitomycin C. Eur J Ophthalmol, 2010, 20(1):
|
|
Epi-LASIK. Curr Opin Ophthalmol, 2003, 14(4): 207-212.
|
55 |
-61.
|
[8] |
Diakonis VF, Kankariya VP, Kounis G, et al. Contralateral-eye study of surface refractive treatments: clinical and confocal microscopy evaluation. J Cataract Refract Surg, 2014, 40(2):224-231. DOI: 10.1016/j.jcrs.2013.07.049.
|
[9] |
Reilly CD, Panday V, Lazos V, et al. PRK vs LASEK vs Epi-LASIK: a comparison of corneal haze, postoperative pain and visual recovery in moderate to high myopia. Nepal J Ophthalmol, 2010, 2(2): 97-104. DOI: 10.3126/nepjoph.v2i2.3715.
|
[7] |
Winkler von Mohrensfels C, Khoramnia R, Maier M, et al.EpiLASIK with mitomycin C. Eur J Ophthalmol, 2010, 20(1):
|
[10] |
Kaluzny BJ, Szkulmowski M, Bukowska DM, et al. Spectral OCT with speckle contrast reduction for evaluation of the
|
|
healing process after PRK and transepithelial PRK. Biomed Opt Express, 2014, 5(4): 1089-1098. DOI: 10.1364/BOE.5.001089.
|
55 |
-61.
|
[8] |
Diakonis VF, Kankariya VP, Kounis G, et al. Contralateral-eye study of surface refractive treatments: clinical and confocal microscopy evaluation. J Cataract Refract Surg, 2014, 40(2):224-231. DOI: 10.1016/j.jcrs.2013.07.049.
|
[9] |
Reilly CD, Panday V, Lazos V, et al. PRK vs LASEK vs Epi-LASIK: a comparison of corneal haze, postoperative pain and visual recovery in moderate to high myopia. Nepal J Ophthalmol, 2010, 2(2): 97-104. DOI: 10.3126/nepjoph.v2i2.3715.
|
[11] |
Aslanides IM, Georgoudis PN, Selimis VD, et al. Single-step transepithelial ASLA (SCHWIND) with mitomycin-C for
|
|
the correction of high myopia: long term follow-up. Clin Ophthalmol, 2015, 9: 33-41. DOI: 10.2147/OPTH.S73424.
|
[10] |
Kaluzny BJ, Szkulmowski M, Bukowska DM, et al. Spectral OCT with speckle contrast reduction for evaluation of the
|
|
healing process after PRK and transepithelial PRK. Biomed Opt Express, 2014, 5(4): 1089-1098. DOI: 10.1364/BOE.5.001089.
|
[12] |
McAlinden C, Skiadaresi E, Moore JE. Visual and refractive outcomes following myopic laser-assisted subepithelial
|
|
keratectomy with a flying-spot excimer laser. J Cataract Refract Surg, 2011, 37(5): 901-906. DOI: 10.1016/j.jcrs.2011.01.013.
|
[11] |
Aslanides IM, Georgoudis PN, Selimis VD, et al. Single-step transepithelial ASLA (SCHWIND) with mitomycin-C for
|
|
the correction of high myopia: long term follow-up. Clin Ophthalmol, 2015, 9: 33-41. DOI: 10.2147/OPTH.S73424.
|
[13] |
Shalaby A, Kaye GB, Gimbel HV. Mitomycin C in photorefractive keratectomy. J Refract Surg, 2009, 25(Suppl): S93-S97.
|
[14] |
McAlinden C, Skiadaresi E, Moore JE. Hyperopic LASEK treatments with mitomycin C using the SCWINDAMARIS.J Refract Surg, 2011, 27(5): 380-383. DOI: 10.3928/1081597X-20101104-01.
|
[12] |
McAlinden C, Skiadaresi E, Moore JE. Visual and refractive outcomes following myopic laser-assisted subepithelial
|
|
keratectomy with a flying-spot excimer laser. J Cataract Refract Surg, 2011, 37(5): 901-906. DOI: 10.1016/j.jcrs.2011.01.013.
|
[15] |
Wallau AD, Campos M. One-year outcomes of a bilateral randomised prospective clinical trial comparing PRK with
|
|
mitomycin C and LASIK. Br J Ophthalmol, 2009, 93(12): 1634-1638. DOI: 10.1136/bjo.2008.152579.
|
[16] |
Moshirfar M, Schliesser JA, Chang JC, et al. Visual outcomes after wavefront-guided photorefractive keratectomy and wavefront-guided laser in situ keratomileusis: Prospective comparison. J Cataract Refract Surg, 2010, 36(8): 1336-1343.DOI: 10.1016/j.jcrs.2010.02.012.
|
[13] |
Shalaby A, Kaye GB, Gimbel HV. Mitomycin C in photorefractive keratectomy. J Refract Surg, 2009, 25(Suppl): S93-S97.
|
[14] |
McAlinden C, Skiadaresi E, Moore JE. Hyperopic LASEK treatments with mitomycin C using the SCWINDAMARIS.J Refract Surg, 2011, 27(5): 380-383. DOI: 10.3928/1081597X-20101104-01.
|
[17] |
Manche EE, Haw WW. Wavefront-guided laser in situ keratomileusis (Lasik) versus wavefront-guided photorefractive keratectomy (Prk): a prospective randomized eye-to-eye comparison (an American Ophthalmological Society thesis).Trans Am Ophthalmol Soc, 2011, 109: 201-220.
|
[18] |
王璐, 王雁. 角膜表层屈光手术后疼痛控制的研究进展.中华眼视光学与视觉科学杂志, 2014, 16(1): 57-60, 64. DOI:10.3760/cma.j.issn.1674-845X.2014.01.014.
|
[19] |
张钰, 陈跃国. 当代准分子激光角膜表层消融术. 中华眼视光学与视觉科学杂志, 2016, 18(2): 65-68. DOI:10.3760/cma.j.issn.1674-845X.2016.02.001.
|
[20] |
Nien CJ, Flynn KJ, Chang M, et al. Reducing peak corneal haze after photorefractive keratectomy in rabbits: prednisolone acetate 1.00% versus cyclosporine A 0.05%. J Cataract Refract Surg, 2011, 37(5): 937-944. DOI: 10.1016/j.jcrs.2010.11.035.
|
[21] |
张钰, 陈跃国, 夏英杰. LASEK术后应用0.5%氯替泼诺滴眼液短程疗法与0.1%氟米龙滴眼液长程疗法的临床效果比较.中华实验眼科杂志, 2015, 33(7): 646-649. DOI: 10.3760/cma.j.issn.2095-0160.2015.07.016.
|
[22] |
王勤美, 许琛琛. 激光表层角膜屈光手术的回归. 中华眼视光学与视觉科学杂志, 2015, 17(12): 708-711. DOI:10.3760/cma.j.issn.1674-845X.2015.12.002.
|
[23] |
Leccisotti A. Photorefractive keratectomy with mitomycin C after deep anterior lamellar keratoplasty for keratoconus. Cornea,2008, 27(4): 417-420. DOI: 10.1097/ICO.0b013e318164e4b8.
|
[15] |
Wallau AD, Campos M. One-year outcomes of a bilateral randomised prospective clinical trial comparing PRK with
|
|
mitomycin C and LASIK. Br J Ophthalmol, 2009, 93(12): 1634-1638. DOI: 10.1136/bjo.2008.152579.
|
[16] |
Moshirfar M, Schliesser JA, Chang JC, et al. Visual outcomes after wavefront-guided photorefractive keratectomy and wavefront-guided laser in situ keratomileusis: Prospective comparison. J Cataract Refract Surg, 2010, 36(8): 1336-1343.DOI: 10.1016/j.jcrs.2010.02.012.
|
[24] |
Ghoreishi M, Naderi BA, Naderi BZ. Visual outcomes of topography-guided excimer laser surgery for treatment of
|
|
patients with irregular astigmatism. Lasers Med Sci, 2014,29(1): 105-111. DOI: 10.1007/s10103-013-1282-9.
|
[17] |
Manche EE, Haw WW. Wavefront-guided laser in situ keratomileusis (Lasik) versus wavefront-guided photorefractive keratectomy (Prk): a prospective randomized eye-to-eye comparison (an American Ophthalmological Society thesis).Trans Am Ophthalmol Soc, 2011, 109: 201-220.
|
[18] |
王璐, 王雁. 角膜表层屈光手术后疼痛控制的研究进展.中华眼视光学与视觉科学杂志, 2014, 16(1): 57-60, 64. DOI:10.3760/cma.j.issn.1674-845X.2014.01.014.
|
[19] |
张钰, 陈跃国. 当代准分子激光角膜表层消融术. 中华眼视光学与视觉科学杂志, 2016, 18(2): 65-68. DOI:10.3760/cma.j.issn.1674-845X.2016.02.001.
|
[20] |
Nien CJ, Flynn KJ, Chang M, et al. Reducing peak corneal haze after photorefractive keratectomy in rabbits: prednisolone acetate 1.00% versus cyclosporine A 0.05%. J Cataract Refract Surg, 2011, 37(5): 937-944. DOI: 10.1016/j.jcrs.2010.11.035.
|
[21] |
张钰, 陈跃国, 夏英杰. LASEK术后应用0.5%氯替泼诺滴眼液短程疗法与0.1%氟米龙滴眼液长程疗法的临床效果比较.中华实验眼科杂志, 2015, 33(7): 646-649. DOI: 10.3760/cma.j.issn.2095-0160.2015.07.016.
|
[22] |
王勤美, 许琛琛. 激光表层角膜屈光手术的回归. 中华眼视光学与视觉科学杂志, 2015, 17(12): 708-711. DOI:10.3760/cma.j.issn.1674-845X.2015.12.002.
|
[23] |
Leccisotti A. Photorefractive keratectomy with mitomycin C after deep anterior lamellar keratoplasty for keratoconus. Cornea,2008, 27(4): 417-420. DOI: 10.1097/ICO.0b013e318164e4b8.
|
[25] |
Majmudar PA, Schallhorn SC, Cason JB, et al. Mitomycin-C in corneal surface excimer laser ablation techniques: a report
|
|
by the American Academy of Ophthalmology. Ophthalmology,2015, 122(6): 1085-1095. DOI: 10.1016/j.ophtha.2015.01.019.
|
[24] |
Ghoreishi M, Naderi BA, Naderi BZ. Visual outcomes of topography-guided excimer laser surgery for treatment of
|
|
patients with irregular astigmatism. Lasers Med Sci, 2014,29(1): 105-111. DOI: 10.1007/s10103-013-1282-9.
|
[25] |
Majmudar PA, Schallhorn SC, Cason JB, et al. Mitomycin-C in corneal surface excimer laser ablation techniques: a report
|
|
by the American Academy of Ophthalmology. Ophthalmology,2015, 122(6): 1085-1095. DOI: 10.1016/j.ophtha.2015.01.019.
|
|
|
|